| Item Type | Name |
|
Concept
|
Translocation, Genetic
|
|
Academic Article
|
Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56).
|
|
Academic Article
|
Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.
|
|
Academic Article
|
Detection of residual proliferating leukemic cells by fluorescence in situ hybridization in CML patients in complete remission after interferon treatment.
|
|
Academic Article
|
A novel translocation t(3;21)(p21;q22) in acute myelogenous leukemia preceding a late-appearing Philadelphia chromosome.
|
|
Academic Article
|
Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.
|
|
Academic Article
|
Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.
|
|
Academic Article
|
The association of specific "favorable" cytogenetic abnormalities with secondary leukemia.
|
|
Academic Article
|
Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.
|
|
Academic Article
|
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
|
|
Academic Article
|
The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.
|
|
Academic Article
|
Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity.
|
|
Academic Article
|
Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics.
|
|
Academic Article
|
Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia.
|
|
Academic Article
|
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation.
|
|
Academic Article
|
Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results.
|
|
Academic Article
|
The importance of cytogenetic studies in adult acute lymphocytic leukemia.
|
|
Academic Article
|
Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia.
|
|
Academic Article
|
Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).
|
|
Academic Article
|
[Role of retinoic acid in the treatment of acute promyelocytic leukemia].
|
|
Academic Article
|
Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes.
|
|
Academic Article
|
Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance.
|
|
Academic Article
|
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing.
|
|
Academic Article
|
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.
|
|
Academic Article
|
Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome.
|
|
Academic Article
|
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
|
|
Academic Article
|
Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions?
|
|
Academic Article
|
Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.
|
|
Academic Article
|
Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
|
|
Academic Article
|
CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis.
|
|
Academic Article
|
Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratory.
|
|
Academic Article
|
Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21.
|
|
Academic Article
|
Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside.
|
|
Academic Article
|
Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia.
|
|
Academic Article
|
Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias.
|
|
Academic Article
|
AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
|
|
Academic Article
|
Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.
|
|
Academic Article
|
t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
|
|
Academic Article
|
Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation.
|
|
Academic Article
|
Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody.
|
|
Academic Article
|
Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.
|
|
Academic Article
|
Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features.
|
|
Academic Article
|
Acute myeloid leukemia--major progress over four decades and glimpses into the future.
|
|
Academic Article
|
Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
|
|
Academic Article
|
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
|
|
Academic Article
|
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia.
|
|
Academic Article
|
Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
|
|
Academic Article
|
Acute lymphoblastic leukemia in adolescents and young adults.
|
|
Academic Article
|
Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
|
|
Academic Article
|
t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
|
|
Academic Article
|
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.
|
|
Academic Article
|
Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis.
|
|
Academic Article
|
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.
|
|
Academic Article
|
Core binding factor acute myelogenous leukemia-2021 treatment algorithm.
|
|
Academic Article
|
Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy.
|
|
Academic Article
|
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
|